Literature DB >> 15934306

Correlation between loss of PTEN expression and PKB/AKT phosphorylation in hepatocellular carcinoma.

Zhifang Yang1, Jilin Yi, Xingrui Li, Wei Long.   

Abstract

The clinical significance of phosphatase and tensin homolog deleted on chromosome ten (PTEN) protein expression and the correlation between the expression of PTEN and phosphorylation of protein kinase B (PKB/AKT) in human hepatocellular carcinoma (HCC) were investigated. The expression of PTEN and phospho-AKT was detected by SP immunohistochemical technique and Western blotting in 35 cases of HCC, 15 cases of liver cirrhosis and 8 cases of normal tissues. The correlation between the expression of PTEN and PKB/AKT in HCC was analyzed. The results showed that the positive expression of PTEN in HCC (62.9%, 0.085 +/- 0.021) was significantly lower than that in liver cirrhosis and normal tissues (P < 0. 01). The expression level of PTEN was related to the differentiation degree of HCC and the status of metastasis (P < 0.05). Western blotting revealed a significant inverse correlation between PTEN and phospho-AKT (r = -0.818, P < 0.01). These results demonstrated that down-regulation or loss of PTEN, which may not be able to effectively inhibit the hyper-phosphorylation of PKB/AKT, might play an important role in tumorigenesis and progression of HCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934306     DOI: 10.1007/BF02831384

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression.

Authors:  Y E Whang; X Wu; H Suzuki; R E Reiter; C Tran; R L Vessella; J W Said; W B Isaacs; C L Sawyers
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

2.  PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model.

Authors:  L P Weng; J L Brown; C Eng
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

3.  PTEN/MMAC1 mutations in hepatocellular carcinomas.

Authors:  Y J Yao; X L Ping; H Zhang; F F Chen; P K Lee; H Ahsan; C J Chen; P H Lee; M Peacocke; R M Santella; H C Tsou
Journal:  Oncogene       Date:  1999-05-20       Impact factor: 9.867

Review 4.  Protean PTEN: form and function.

Authors:  Kristin A Waite; Charis Eng
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

5.  PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.

Authors:  J Li; C Yen; D Liaw; K Podsypanina; S Bose; S I Wang; J Puc; C Miliaresis; L Rodgers; R McCombie; S H Bigner; B C Giovanella; M Ittmann; B Tycko; H Hibshoosh; M H Wigler; R Parsons
Journal:  Science       Date:  1997-03-28       Impact factor: 47.728

6.  PTEN/MMAC1 mutations in hepatocellular carcinomas: somatic inactivation of both alleles in tumors.

Authors:  N Kawamura; H Nagai; K Bando; M Koyama; S Matsumoto; T Tajiri; M Onda; J Fujimoto; T Ueki; N Konishi; T Shiba; M Emi
Journal:  Jpn J Cancer Res       Date:  1999-04
  6 in total
  4 in total

1.  HNF4α-Deficient Fatty Liver Provides a Permissive Environment for Sex-Independent Hepatocellular Carcinoma.

Authors:  Baharan Fekry; Aleix Ribas-Latre; Corrine Baumgartner; Alaa M T Mohamed; Mikhail G Kolonin; Frances M Sladek; Mamoun Younes; Kristin L Eckel-Mahan
Journal:  Cancer Res       Date:  2019-10-01       Impact factor: 12.701

2.  Activation of LKB1-Akt pathway independent of phosphoinositide 3-kinase plays a critical role in the proliferation of hepatocellular carcinoma from nonalcoholic steatohepatitis.

Authors:  Nuria Martínez-López; Marta Varela-Rey; David Fernández-Ramos; Ashwin Woodhoo; Mercedes Vázquez-Chantada; Nieves Embade; Luis Espinosa-Hevia; Francisco Javier Bustamante; Luis A Parada; Manuel S Rodriguez; Shelly C Lu; José M Mato; Maria L Martínez-Chantar
Journal:  Hepatology       Date:  2010-11       Impact factor: 17.425

3.  Expression of PTEN, PPM1A and P-Smad2 in hepatocellular carcinomas and adjacent liver tissues.

Authors:  Shu-Kun Wu; Bao-Ju Wang; Yan Yang; Xin-Hua Feng; Xi-Ping Zhao; Dong-Liang Yang
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

4.  MicroRNA pharmacogenomics based integrated model of miR-17-92 cluster in sorafenib resistant HCC cells reveals a strategy to forestall drug resistance.

Authors:  Faryal Mehwish Awan; Anam Naz; Ayesha Obaid; Aqsa Ikram; Amjad Ali; Jamil Ahmad; Abdul Khaliq Naveed; Hussnain Ahmed Janjua
Journal:  Sci Rep       Date:  2017-09-13       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.